Published in Vaccine Weekly, June 8th, 2011
"This study assesses the safety and immunogenicity of an intradermally administered influenza...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.